Haemonetics HAE Cash Flow Statement
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| —— | $44.74M+15.7% | $38.68M+13.7% | $34.03M-41.3% | $57.98M+54.6% | ||
| $27.32M-0.2% | $27.39M-3.1% | $28.26M-1.7% | $28.76M+1.9% | $28.21M-2.8% | ||
| $9.13M+17.0% | $7.8M+2.8% | $7.59M-18.5% | $9.31M+34.2% | $6.94M-15.5% | ||
| $77.25M+731% | $9.3M+8.3% | $8.58M— | $0— | —— | ||
| $178K-18.3% | $218K+191% | $75K-69.1% | $243K-78.4% | $1.13M+604% | ||
| $22.24M+301% | -$11.06M-252% | $7.26M+304% | -$3.56M+65.6% | -$10.34M-684% | ||
| -$8.46M+38.9% | -$13.84M+36.4% | -$21.76M-560% | -$3.3M-1,005% | $364K-97.9% | ||
| —— | -$6.7M— | —— | -$47.9M— | —— | ||
| $5.98M+188% | $2.07M+140% | $865K-52.3% | $1.81M-2.7% | $1.86M-48.1% | ||
| $70.94M-24.2% | $93.56M-16.0% | $111.32M+540% | $17.4M-85.1% | $116.56M+166% | ||
| $17.66M+178% | $6.35M+26.6% | $5.02M+33.6% | $3.75M-76.0% | $15.64M+83.0% | ||
| $60.18M— | $0— | $0— | $0— | —— | ||
| $0-100% | $10.11M+28.2% | $7.88M-56.4% | $18.08M+403% | $3.6M+13.0% | ||
| $526K+21.8% | $432K+260% | $120K-59.6% | $297K-87.9% | $2.45M+876% | ||
| -$86.61M-194% | -$29.47M+3.3% | -$30.47M+7.7% | -$33M— | —— | ||
| $100M— | —— | —— | —— | $150M— | ||
| $0— | $0— | $0— | $0— | —— | ||
| -$4.69M-400% | $1.56M+0.1% | $1.56M-0.1% | $1.56M0.0% | $1.56M+0.1% | ||
| —— | $1.15M+1,721% | $63K-86.4% | $462K— | —— | ||
| $46K-71.3% | $160K+1,043% | $14K-99.7% | $4.78M— | $0-100% | ||
| -$13K+7.1% | -$14K+64.1% | -$39K-8.3% | -$36K-33.3% | -$27K+81.9% | ||
| $0— | $0— | $0— | $0— | —— | ||
| -$101.5M— | $0+100% | -$76.55M-3,035% | -$2.44M— | —— | ||
| —— | $810K— | —— | $4.18M— | —— | ||
| -$117.93M-276% | $66.94M— | $0+100% | -$13.87M— | —— | ||
| $0-100% | $1.32M-35.6% | $2.06M-15.6% | $2.44M-7.6% | $2.64M-21.1% | ||
| $77.25M+731% | $9.3M+8.3% | $8.58M— | $0— | —— | ||
| -$469.75K0.0% | -$469.75K0.0% | -$469.75K0.0% | -$469.75K+91.8% | -$5.76M0.0% | ||
| $0— | $0— | $0— | $0— | —— | ||
| $5.89M— | —— | —— | -$3.35M-16.8% | -$2.86M-166% | ||
| $0-100% | $10.11M+28.2% | $7.88M-56.4% | $18.08M+403% | $3.6M+13.0% | ||
| $526K+21.8% | $432K+260% | $120K-59.6% | $297K-87.9% | $2.45M+876% | ||
| -$9.3M+30.8% | -$13.44M+24.0% | -$17.69M-54.4% | -$11.46M-35.4% | -$8.46M-43.6% | ||
| —— | $0— | $0— | $0— | —— | ||
| $0— | $0— | $0— | $0— | —— | ||
| $1.79M-31.6% | $2.62M— | $0-100% | $3.48M+87.2% | $1.86M-38.8% | ||
| $0— | $0— | $0— | $0-100% | $22.05M0.0% | ||
| $0— | $0— | $0— | $0— | —— | ||
| —— | $0— | $0— | $0— | —— | ||
| -$13K+7.1% | -$14K+64.1% | -$39K-8.3% | -$36K-33.3% | -$27K+81.9% | ||
| —— | $0— | $0— | $0— | —— | ||
| $75M0.0% | $75M0.0% | $75M0.0% | $75M+61.7% | $46.38M0.0% | ||
| $0— | $0— | $0— | $0— | —— | ||
| $0— | $0— | $0— | $0-100% | $62.5M0.0% | ||
| $11.81M0.0% | $11.81M0.0% | $11.81M0.0% | $11.81M— | $0— | ||
| $8.95M0.0% | $8.95M0.0% | $8.95M0.0% | $8.95M— | $0— | ||
| $53.28M-38.9% | $87.22M-18.0% | $106.31M+679% | $13.64M-86.5% | $100.91M+187% | ||
| $53.28M-38.9% | $87.22M-18.0% | $106.31M+679% | $13.64M-86.5% | $100.91M+187% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Haemonetics's cash flow data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.